Creteil, France

Michael Rivard

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael Rivard: Innovator in Pharmaceutical Chemistry

Introduction

Michael Rivard is a notable inventor based in Créteil, France, recognized for his contributions to pharmaceutical chemistry. He holds a total of six patents, showcasing his innovative approach to addressing significant health challenges.

Latest Patents

Among his latest patents is the invention of highly efficient NRF2 activators-co-releasing molecule hybrids. This invention focuses on their use in the treatment of inflammatory or cardiovascular diseases, detailing a process for their preparation. The invention relates to molecules capable of increasing HO-1 protein expression while simultaneously releasing carbon monoxide, with specific carbonyl metal complexes utilized in the formulation. Another significant patent involves derivatives of oxazaphosphorines that are pre-activated. This invention outlines methods for preparing these derivatives, their pharmaceutical compositions, and their therapeutic applications, particularly in cancer treatment.

Career Highlights

Michael Rivard has made substantial contributions to the field through his work at prestigious institutions. He has been associated with the Institut Gustave Roussy and the Centre National de la Recherche Scientifique, where he has furthered research and development in pharmaceutical innovations.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues, including Thierry Martens and Angelo Paci. These partnerships have likely enhanced his research and contributed to his innovative outputs.

Conclusion

Michael Rivard's work exemplifies the intersection of innovation and healthcare, with his patents addressing critical medical needs. His contributions continue to impact the field of pharmaceutical chemistry significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…